In subjects with family history of AD, higher insulin resistance has been associated with reduced cerebral glucose metabolism [46], as well as changes in CSF Aβ and tau and worse memory performance, especially in APOE e4 carriers [47]. This evidence concerns the gene MAPT and Alzheimer disease.